
Payal Ganguly
Author
LeadershipInterviewWe wanted to ensure a steady supply of Ozempic: MD of Novo Nordisk India
Novo Nordisk India head Vikrant Shrotriya on Ozempic’s delayed launch in India, leading the fight against diabetes and obesity, and ensuring accessibility
Explore More Authors
Advertisement
Advertisement
Advertisement